Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Beckers HJM et al. – Brinzolamide 1%/timolol 0.5% is a new fixed–combination for the treatment of open–angle glaucoma or ocular hypertension. Brinzolamide/timolol has a favorable safety profile, with an incidence of ocular burning and stinging <5%. Published data show that brinzolamide 1%/timolol 0.5% and dorzolamide 2%/timolol 0.5% have similar efficacies for lowering intraocular pressure.

 

Related Articles

Glaucoma and dry eye data from Germany
Ophthalmology Times Europe, 10/27/09    Relevance Score: 93%

Understanding the Importance of IOP Variables in Glaucoma
Survey of Ophthalmology, 10/23/09    Relevance Score: 92%

Characteristics of respondents with glaucoma and dry eye in a national panel survey
Clinical Ophthalmology, 11/13/09    Relevance Score: 91%

Gene-directed therapy in glaucoma may have future clinical applications
Ophthalmology Times Europe, 10/22/09    Relevance Score: 91%

Sequential Glaucoma Implants in Refractory Glaucoma
American Journal of Ophthalmology, 10/20/09    Relevance Score: 91%

Today in Clinical Pharmacology...keeping you current

Vitreous Nonsteroidal Antiinflammatory Drug Concentrations and Prostaglandin E2 Levels in Vitrectomy Patients Treated With Ketorolac 0.4%, Bromfenac 0.09%, and Nepafenac 0.1%
Retina, 11/25/09

Infliximab and anterior optic neuropathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/23/09

Retinal Arteriolar Vascular Reactivity in Untreated and Progressive Primary Open Angle Glaucoma
Investigative Ophthalmology and Visual Science, 11/20/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address